Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease
As a result of increased prevalence of obesity worldwide, non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of chronic liver disease. Although most NAFLD cases remain benign, some progress to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. Th...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a2dc2abff5b64dabb16e2113912d964a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|